Advanced hepatocellular carcinoma. Review of targeted molecular drugs
Read
1243
Timeswas read the article
316
Total PDF
927
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 July | 18 | 1 | 19 |
| 2024 June | 20 | 1 | 21 |
| 2024 May | 12 | 4 | 16 |
| 2024 April | 22 | 5 | 27 |
| 2024 March | 19 | 2 | 21 |
| 2024 February | 23 | 7 | 30 |
| 2024 January | 34 | 8 | 42 |
| 2023 December | 39 | 11 | 50 |
| 2023 November | 31 | 11 | 42 |
| 2023 October | 44 | 8 | 52 |
| 2023 September | 11 | 1 | 12 |
| 2023 August | 12 | 4 | 16 |
| 2023 July | 5 | 6 | 11 |
| 2023 June | 21 | 5 | 26 |
| 2023 May | 45 | 0 | 45 |
| 2023 April | 47 | 1 | 48 |
| 2023 March | 34 | 1 | 35 |
| 2023 February | 6 | 5 | 11 |
| 2023 January | 14 | 11 | 25 |
| 2022 December | 12 | 2 | 14 |
| 2022 November | 9 | 11 | 20 |
| 2022 October | 9 | 7 | 16 |
| 2022 September | 15 | 5 | 20 |
| 2022 August | 11 | 8 | 19 |
| 2022 July | 12 | 5 | 17 |
| 2022 June | 13 | 3 | 16 |
| 2022 May | 12 | 7 | 19 |
| 2022 April | 22 | 4 | 26 |
| 2022 March | 27 | 11 | 38 |
| 2022 February | 46 | 5 | 51 |
| 2022 January | 22 | 3 | 25 |
| 2021 December | 35 | 5 | 40 |
| 2021 November | 21 | 7 | 28 |
| 2021 October | 36 | 12 | 48 |
| 2021 September | 37 | 8 | 45 |
| 2021 August | 5 | 3 | 8 |
| 2021 July | 10 | 7 | 17 |
| 2021 June | 8 | 5 | 13 |
| 2021 May | 9 | 6 | 15 |
| 2021 April | 13 | 8 | 21 |
| 2021 March | 8 | 12 | 20 |
| 2021 February | 3 | 7 | 10 |
| 2021 January | 7 | 6 | 13 |
| 2020 December | 4 | 7 | 11 |
| 2020 November | 3 | 6 | 9 |
| 2020 October | 4 | 5 | 9 |
| 2020 September | 5 | 4 | 9 |
| 2020 August | 7 | 6 | 13 |
| 2020 July | 4 | 1 | 5 |
| 2020 June | 3 | 1 | 4 |
| 2020 May | 5 | 3 | 8 |
| 2020 April | 7 | 3 | 10 |
| 2020 March | 1 | 3 | 4 |
| 2020 February | 7 | 5 | 12 |
| 2020 January | 3 | 4 | 7 |
| 2019 December | 4 | 7 | 11 |
| 2019 November | 6 | 5 | 11 |
| 2019 August | 1 | 1 | 2 |
| 2019 July | 1 | 2 | 3 |
| 2019 June | 3 | 4 | 7 |
Show all
